EUVIMEDOdkrijte EUVIMED
CrossrefInformačná karta

The Role of Therapeutic Plasma Exchange in Treating Hypertriglyceridemia‐Associated Acute Pancreatitis: A Real‐World Effectiveness Analysis Using the TriNetX Global Collaborative Network

Nisar Amin, Tim Carll, Harleen Chela, Amir Kamran, Geoffrey D. Wool, Ebubekir Daglilar

Journal of Clinical Apheresis · 2025-08 · 40 (4)

DOI: 10.1002/jca.70053 ↗
AbstraktBibliografické údaje

Abstrakt

ABSTRACT Therapeutic plasma exchange (TPE) is used to lower triglyceride levels in patients with severe hypertriglyceridemia‐associated acute pancreatitis (HTG‐AP). However, evidence supporting the effectiveness of TPE in preventing end‐organ damage remains limited. This retrospective cohort study was conducted using the TriNetX database to evaluate adults with acute pancreatitis, triglyceride levels > 1000 mg/dL, and “worrisome criteria”, defined as clinical indicators of disease severity such as fever, leukocytosis, elevated lactate, or signs of shock. Patients receiving TPE within 3 days of diagnosis were compared with patients with no TPE within 30 days. Outcomes included triglyceride reduction to < 500 mg/dL, ICU admission, end‐organ damage, and mortality. Of 14 188 patients with HTG‐AP, 3% ( n = 419) received TPE; 97% ( n = 13 237) were treated without TPE. After 1:1 propensity‐score matching, 2 well‐matched, 412‐patient cohorts were created. More patients in the TPE cohort had a reduction in triglyceride levels to < 500 mg/dL at 1 week (81% vs. 40%, p < 0.001) and 1 month (86% vs. 48%, p < 0.001). However, the TPE cohort also had higher ICU admission rates (39% vs. 19%, p < 0.001). No significant differences in organ failure rates were observed at 1 week (4.4% vs. 3.3%, p = 0.47) or 1 month (5.8% vs. 5.0%, p = 0.71). Similarly, 30‐day (4.4% vs. 6.3%, p = 0.21) and 3‐month (5.3% vs. 7.8%, p = 0.16) all‐cause mortality were comparable between the cohorts. In patients with HTG‐AP, use of TPE within 3 days of diagnosis reduces triglyceride levels effectively but does not significantly reduce the risk of end‐organ damage or mortality. TPE is associated with increased ICU care requirements, which may reflect protocolized ICU admission.

Vedomosti, ktoré zodpovedajú vašej práci.

Od bezplatného začiatku cez osobnú rešerš literatúry až po kompletný Research Suite.

Zobraziť tarify →

Sú zahrnuté všetky plné texty vydavateľov?

Nie. Bibliografické záznamy, abstrakty a plné texty sú odlišné typy obsahu. To, či je plný text dostupný, závisí od zdroja, Open Access a vašich existujúcich licencií. Tarif EUVIMED nenahrádza dodatočné práva vydavateľa.

Zobraziť tarify →